Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
DE000A1EWVY8
Mon, 13.01.2025
Formycon AG
Presse Release // January 13, 2025
Teva becomes strategic commercialization partner for Formycon’s biosimilar candidate FYB203 (Eylea®/ aflibercept) in major parts of Europe and Israel
Planegg-Martinsried, Germany – Klinge Biopharma GmbH (Klinge), the licensee and exclusive global commercialization rights holder for FYB203, Formycon’s biosimila [ … ]
Thu, 09.01.2025
Formycon AG
Press Release // January 9, 2025
Formycon included in TecDAX Index of Deutsche Börse
Formycon to join the ranks of the 30 leading listed technology companies
Uplisting to the Prime Standard, inclusion in the SDAX, and robust business development further enhance the stock’s appeal
Entry into the TecDAX becomes effective as of January 13, 2025
[ … ]
Wed, 08.01.2025
Formycon AG
Press Release // January 8, 2025
Formycon and Fresenius Kabi Canada receive Health Canada’s approval for FYB202/Otulfi® (ustekinumab), a biosimilar to Stelara®
Otulfi® approved by Health Canada for both subcutaneous and intravenous formulations to treat serious inflammatory diseases
Health Canada joins the FDA and the European Commission in gra [ … ]